Exploring P2X receptor activity: A journey from cellular impact to electrophysiological profiling
Calvin Dunker1, Laura Vinnenberg2, Andreas Isaak3
1European Institute for Molecular Imaging (EIMI), Roentgenstr 16, University of Muenster, 48149 Muenster, Germany; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Roentgenweg 13, 72076, Tuebingen, Germany.
Biochemical Pharmacology
|September 20, 2024
Summary
Choosing the right host cell line is crucial for P2X4 and P2X7 receptor assays. The 1321N1 cell line offers superior performance for human P2X4 receptor studies, impacting drug discovery for inflammatory disorders.
Area of Science:
- Pharmacology and Cell Biology
- Receptor Pharmacology
- Immunology
Background:
- In vitro pharmacological assays require genetically modified cell lines overexpressing target proteins.
- Host cell line selection critically influences experimental outcomes and assay reliability.
- P2X4 and P2X7 receptors are key targets in inflammatory disorders.
Purpose of the Study:
- To functionally characterize P2X7 and P2X4 receptor modulators.
- To investigate the impact of different host cell lines (HEK-293, HEK-293FT, 1321N1) on receptor activity.
- To establish an electrophysiological protocol for human CD4+ T-cells.
Main Methods:
- Cellular assays and advanced electrophysiology (patch-clamp).
- Systematic investigation of agonist and antagonist activity on human and murine P2X4/P2X7 receptors across different cell lines.
- Development of a repetitive patch-clamp protocol for ATP-mediated currents in human CD4+ T-cells.
Main Results:
- Host cell line significantly impacts P2X4 and P2X7 receptor modulator activity.
- 1321N1 cells demonstrated superior consistency for human P2X4 receptor studies (agonist activity, antagonist potency, signal window).
- P2X7 and P2X4 receptors are vital for immune cell regulation, confirmed by patch-clamp recordings in T-cells.
Conclusions:
- Host cell choice is a critical variable in P2X4 and P2X7 receptor assay development.
- The 1321N1 cell line is recommended for human P2X4 receptor research.
- P2X7 and P2X4 receptors represent promising therapeutic targets for inflammatory conditions.
